echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Spotlight on Serological Markers to Explore Correlations Between Obesity and Prostate Cancer Risk

    Spotlight on Serological Markers to Explore Correlations Between Obesity and Prostate Cancer Risk

    • Last Update: 2022-09-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Guided reading




    The androgen and insulin-like growth factor-1 (IGF-1) regulatory axis is known to play critical roles in the progression of prostate cancer




    The data and samples of this nested case-control study were derived from the large PCPT (SWOG-S9217) trial.




    01The relationship between sex steroids and IGFs/IGFBPs and BMI


    BMI was significantly associated with sex steroids and IGFs/IGFBPs



    02Effect of sex steroids and IGFs/IGFPBs on obesity-related prostate cancer risk


    Elevated BMI increased cancer risk in the high-risk group (OR=1.




    Analysis conclusion

    The present findings suggest that IGF-1 regulates axis-related serological markers, particularly IGFs and IGFBP2, that may influence obesity-related prostate cancer risk
    .

    More research is needed in the future to determine the role of these potential mediators, to understand the biological mechanisms associated with obesity and prostate cancer risk, and to help researchers and clinicians develop more effective prostate cancer prevention strategies and treatments
    .

    references:

    Chau CH, Till C, Price DK, et al.
    Serum markers, obesity and prostate cancer risk: results from the prostate cancer prevention trial.
    Endocr Relat Cancer.
    2022 Jan 20;29(2):99-109 .

    Editor: Wang Mumu

    Reviewer: LR

    Executive: Wang Mumu

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.